Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Footer revision updated to Revision: v3.3.3 and the HHS Vulnerability Disclosure link removed, along with the Revision: v3.3.2 note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T10:15:08.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the page footer, with no substantive changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:26:12.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The changes update the page text to describe PubMed auto-filled publications and adjust the wording around that feature, and the revision label changed from v3.2.0 to v3.3.1; these adjustments do not affect study data, endpoints, eligibility criteria, or outcomes, To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T13:20:04.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The funding-status notice about lapse in government funding was removed from the page. The study details and eligibility criteria remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:29:48.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The screenshots show minor UI updates to the Study Details page (e.g., formatting and section headings) without changes to the substantive study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:10:10.000Z thumbnail image
  9. Check
    71 days ago
    Change Detected
    Summary
    Added a 2025 Nature Medicine publication citation for KEYNOTE-426 (Pembrolizumab plus axitinib vs sunitinib) detailing 5-year survival and biomarker analyses, to the Publications section. Removed the 'Online ahead of print' note for the same article.
    Difference
    0.1%
    Check dated 2025-10-26T20:36:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.